Risultati per: Linee guida sulla dermatite atopica (eczema)
Questo è quello che abbiamo trovato per te
Linee guida sulla diagnosi e gestione dell’ipertensione in gravidanza
Linee guida per l’ictus per il Regno Unito e l’Irlanda
La National Clinical Guideline for Stroke fornisce una guida pratica […]
Can co-created knowledge mobilisation interventions alter and enhance mindlines to improve childhood eczema care? A UK-based Social Impact Framework evaluation
Objective
To evaluate the impact of using knowledge mobilisation interventions to alter and enhance mindlines and improve childhood eczema care.
Design
The eczema mindlines study involved three stages: (1) mapping and confirming eczema mindlines, (2) intervention development and delivery and (3) analysis of intervention impact. The focus of this paper is on stage 3. Data analysis was guided by the Social Impact Framework to address the questions: (1) what is the impact of this study on individuals and groups? (2) what changes in behaviour and practice have occurred due to their involvement? (3) what mechanisms have enabled these impacts or changes to occur? and (4) what are the recommendations and questions arising from this research?
Settings
A deprived inner-city neighbourhood in central England and national/international settings.
Participants
Patients, practitioners and wider community members exposed to the interventions locally, nationally and internationally.
Results
Data revealed tangible multi-level, relational and intellectual impacts. Mechanisms supporting impact included: simplicity and consistency of messages adapted to audience, flexibility, opportunism and perseverance, personal interconnectivity and acknowledgement of emotion. Co-created knowledge mobilisation strategies to alter and enhance mindlines mediated through knowledge brokering were effective in producing tangible changes in eczema care practice and self-management and in ‘mainstreaming’ childhood eczema in positive way across communities. These changes cannot be directly attributed to the knowledge mobilisation interventions, however, the evidence points to the significant contribution made.
Conclusion
Co-created knowledge mobilisation interventions offer a valuable method of altering and enhancing eczema mindlines across lay-practitioner-wider society boundaries. The Social Impact Framework provides comprehensive method of understanding and documenting the complex web of impact occurring as a result of knowledge mobilisation. This approach is transferable to managing other long-term conditions.
Effects of infant feeding with goat milk formula or cow milk formula on atopic dermatitis: protocol of the randomised controlled Goat Infant Formula Feeding and Eczema (GIraFFE) trial
Introduction
Atopic dermatitis (AD) is a chronic, inflammatory skin condition significantly affecting quality of life. A small randomised trial showed an approximately one-third lower incidence of AD in goat milk formula-fed compared with cow milk formula-fed infants. However, due to limited statistical power, AD incidence difference was not found to be significant. This study aims to explore a potential risk reduction of AD by feeding a formula based on whole goat milk (as a source of protein and fat) compared with a formula based on cow milk proteins and vegetable oils.
Methods and analysis
This two-arm (1:1 allocation), parallel, randomised, double-blind, controlled nutritional trial shall enrol up to 2296 healthy term-born infants until 3 months of age, if parents choose to start formula feeding. Ten study centres in Spain and Poland are participating. Randomised infants receive investigational infant and follow-on formulas either based on whole goat milk or on cow milk until the age of 12 months. The goat milk formula has a whey:casein ratio of 20:80 and about 50% of the lipids are milk fat from whole goat milk, whereas the cow milk formula, used as control, has a whey:casein ratio of 60:40 and 100% of the lipids are from vegetable oils. The energy and nutrient levels in both goat and cow milk formulas are the same. The primary endpoint is the cumulative incidence of AD until the age of 12 months diagnosed by study personnel based on the UK Working Party Diagnostic Criteria. The secondary endpoints include reported AD diagnosis, measures of AD, blood and stool markers, child growth, sleep, nutrition and quality of life. Participating children are followed until the age of 5 years.
Ethics and dissemination
Ethical approval was obtained from the ethical committees of all participating institutions.
Trial registration number
NCT04599946.
Diabete:dall'Ospedale Bambino Gesù guida online per genitori
Aiuta a gestire la malattia e ad affrontare sfide quotidiane
Linee guida per la gestione della polmonite grave acquisita in comunità
Trends in the Prevalence of Eczema Among Children in the US
This cross-sectional study of National Health Interview Survey data examines differences among sociodemographic subgroups in reported incidence of eczema in children in the US.
Ictus tra prime cause di morte in Italia, nuove linee guida
Soc. italiana ictus, ‘urge omogeneità cura su tutto territorio’
Scompenso cardiaco acuto: una guida per il medico
Linea guida sulla diagnosi e trattamento della miocardite
Oms, stop marketing cibi malsani per bimbi,nuove linee guida
Aggiornati criteri nutrizionali per 18 categorie alimentari
Linee guida sulla steatosi epatica non alcolica (NAFLD)
Nuovi farmaci per l'obesità a partire dai 12anni, cambiano le linee guida
L’ultimo autorizzato a dicembre.Quando dieta e sport non bastano